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Summary 
Following the emergence of bluetongue (BT) virus serotype 2 on the island of Corsica in 2000, 
annual monovalent vaccination campaigns of the ovine population were conducted between 2001 
and 2003. Despite vaccination, outbreaks were reported from several areas in 2001, but since 
November 2001, the absence of clinical cases in Corsica proves that vaccination is effective. This 
experience in Corsica is examined and, using available data, compared to the situation and the 
vaccination strategies on other Mediterranean islands. In light of the expansion of a new serotype 
of BTV onto these islands, a Mediterranean information network for BT and other emerging 
diseases is proposed. 
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As the ability to control vector populations of insects 
is limited, vaccination against bluetongue (BT) 
remains a very useful disease control tool. Four 
objectives can be sought when using this tool, as 
follows: 
1) prevention of the establishment of BT virus 
(BTV) in an area 
2) reduction of the number of clinical BT cases 
3) eradication of BTV infection 
4) immunisation of animals that will be introduced 
into the affected region. 
After defining the objectives of BT vaccination, the 
following questions remain: 
1) What level of vaccination should be reached? 
2) Which species should be immunised? 
3) Is the objective of eradication feasible? 
4) When should vaccination cease? 
5) How can the arrival of new serotypes be 
prevented? 
In this review we will first present the example of BT 
in Corsica between 2000 and 2002. After a summary 
of the epidemic, the use of vaccination is evaluated 
and then compared with experience in the other 
islands of the western Mediterranean (the Balearic 
islands, Sardinia and Sicily) (Fig. 1). 
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History of bluetongue in Corsica 
2000 and 2001 bluetongue epidemic 
Following the first description of the principal vector 
(Culicoides imicola) in Corsica at the beginning of 
October 2000 (6), 49 outbreaks of BT (involving 
approximately 12 000 sheep) were later recorded on 
the island, whereas BT did not occur in continental 
France (Fig. 2). Serological surveys showed that BTV 
spread throughout the island. Corse-du-Sud was 
more infected with a 41% morbidity rate and twice 
the seropositivity rate of Haute-Corse (24% vs 40% 
in cattle, 16% vs 38% in sheep). Sheep were 
vaccinated with homologous vaccine against BTV-2 
during the winter of 2000-2001. On average, 78% of 
the sheep flocks were vaccinated. Nevertheless, 
335 outbreaks of BT were recorded between July 
and November 2001 and Haute-Corse was more 
affected than Corse-du-Sud (7). The last outbreak of 
BT in Corsica with serotype 2 was recorded on 
8 November 2001. The 2000 and 2001 data confirm 
that BT commenced late in 2000 and ceased after the 
onset of cooler weather in November. A relatively 
mild winter allowed the persistence of infection and 
outbreaks began again the following July. 
 
Figure 2 
Spatial distribution of bluetongue cases in Corsica, 2000 
and 2001 
Source: National Food Directorate (Direction générale de 
l’Alimentation: DGAL) 
Serological prevalence in non-vaccinated cattle 
and sheep 
A total of 113 cattle herds were sampled in spring 
2002, and 48% of the animals were seropositive. 
Corse-du-Sud has a significantly higher prevalence 
(68%) than Haute-Corse (39%). The serological rate 
of infection increased in cattle between the winters 
of 2000-2001 and 2001-2002 (increase of 63% in 
Haute-Corse and 70% in Corse-du-Sud) with a stable 
difference between the two regions. The geographic 
distribution of samples influenced these results, as 
the seropositivity rates (>75%) were higher in coastal 
areas and lower (<25%) in the mountains (Fig. 3). At 
this stage of the epidemic, a substantial portion of 
the cattle population (32% in Corse-du-Sud and 61% 
in Haute-Corse) was still susceptible (seronegative) 
and so could play a role in virus multiplication and 
dissemination. Nevertheless, the highest proportion 
of seronegative cattle occurred in the central areas of 
Corsica where the altitude is high and vector 
abundance is limited. The more affected areas in 
2000 and 2001 were those with more seropositive 
cattle. The amplifying role of cattle in high altitude 
areas would, therefore, seem to be limited. 
 
Figure 3 
Seropositivity against bluetongue virus in cattle in 
Corsica in 2002 
Source: National Food Directorate (Direction générale de 
l’Alimentation: DGAL) 
Assessment of bluetongue virus circulation 
through serological analyses in sentinel cattle 
Despite the vaccination campaign, circulation of 
BTV was observed in sentinel herds of cattle in 
2002. Although the percentage of seroconversion at 
herd level is similar, the raw numbers show that the 
circulation of BTV was higher in Haute-Corse 
(Table I). This has to be compared with the presence 
of C. imicola during eight months from May to 
December 2002. The principal vector of BT is now 
permanently established in Corsica. To summarise 
2000 2001 
5  -  16 4 3 2 
1 No outbreak reported 
75-100% (23) 
50-75% (10) 
25-50% (18) 
0-25% (25) 
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the situation in France in September 2003, neither 
C. imicola nor cases of BT have been found in 
mainland France and clinical BT due to BTV-2 has 
not been observed in Corsica since 8 November 
2001. Vaccination was very effective in reducing 
clinical symptoms but BTV still circulates at a low 
level. 
Table I 
Seroconversions in cattle in Corsica in 2002 
Herds Corse-du-Sud Haute-Corse 
Herd level   
Number of herds 35 48 
Percentage of herds with at 
least one seroconversion 
37.1% (13/35) 64.6% (31/48) 
Animal level   
Number of animals 229 1 495 
Seroconversion 16.6% 12.9% 
Evaluation of vaccination in Corsica 
The possible use of vaccination against BT was 
discussed by the European Union scientific 
committee on animal health and welfare on 27 June 
2000, prior to the initial report of BT in Corsica. At 
the national level, the case was submitted to the 
official risk assessment institution, the French 
Agency for Food Safety (AFSSA: Agence française 
de Sécurité sanitaire des Aliments). The choice to 
vaccinate was largely based on the assumption that 
C. imicola, which had been captured for the first time 
in Corsica, would survive the winter of 2000-2001. It 
was decided to vaccinate sheep, but not other 
species, with the South African attenuated 
monovalent BTV-2 vaccine as only BTV-2 had been 
isolated in the outbreaks of 2000 and 2001. 
Impact of vaccination on serological status of 
ruminants 
Serological status after the first vaccination campaign 
(2000-2001) 
Assuming that there was no contact with vectors 
because of altitude, a sample of 13 herds 
(1 461 animals) vaccinated in February 2001 and 
9 non-vaccinated herds (306 animals) was selected 
(4). These flocks went to summer pastures in 2001. 
Seven months after vaccination they were tested 
using the competitive immunosorbent assay 
(c-ELISA). The seropositivity rate was significantly 
different (χ² = 36.88, p<0.05) (Table II) between the 
two populations. Some positive results in the 
vaccinated population were due to previous 
infection. The non-vaccinated population was taken 
as a control population to calculate the effect of 
vaccination. From the 1 461 animals vaccinated, 43% 
were positive before vaccination and 275 became 
positive after vaccination (out of 831 negative 
animals before vaccination). Vaccination caused 
seroconversion of only 33% of the seronegative 
animals (Fig. 4). This very poor result has been 
explained by the delay between vaccination and 
serology (7 months), the vaccination protocol (single 
vaccination of all sheep, regardless of age) and 
vaccination failure (i.e. excessive delay between 
vaccine reconstitution and injection). These results 
fully explained the poor protection of sheep herds 
during the 2001 epidemic. 
Table II 
Serological results in transhumant sheep 
c-ELISA 
Sheep population 
+ – 
Seropositivity 
rate 
Standard 
deviation 
Vaccinated transhumant 
population 905 556 62% 0.0127 
Non vaccinated 
transhumant population 132 174 43% 0.0283 
 
Figure 4 
Effect of vaccination in transhumant sheep 
Serological status after the second vaccination 
campaign (2001-2002) 
The proportion of BT-seropositive animals is 91% 
on average. The northern and southern areas of 
Corsica show the same results (Table III). The 
serological prevalence in 2002 is obviously very high 
and is the result of a more efficient vaccination 
campaign during the 2001-2002 winter, and also 
because of the very high levels of virus circulating 
during the 2001 epizootic. These data are consistent 
with the absence of clinical BT amongst ruminants 
in Corsica in 2002. 
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Effect of vaccination 
A comparison of mortality and morbidity rates 
between vaccinated and non-vaccinated animals 
shows that non-vaccinated animals are more 
affected, which validates the decision to undertake 
massive vaccination in 2000 (Table IV). 
Table III 
Serological status of vaccinated sheep flocks in Corsica 
Flocks Corse-du-Sud Haute-Corse Total 
Number of flocks 57 50 107 
Number of samples 1 118 1 058 2 176 
Positive 91% 91% 91% 
Negative 7% 7% 7% 
Doubtful 2% 2% 2% 
Table IV 
Bluetongue outbreaks in Corsica in 2001 
Flocks Haute-Corse Corse-du-Sud Total 
Infected flocks    
Total number  211 124 335 
Sheep belonging to 
infected flocks 
63 274 21 664 84 938 
Vaccinated sheep in 
infected flocks 
48 833 17 678 66 511 
Morbidity rate    
Infected flocks 16.67% 14.18% 16.03% 
Vaccinated animals 
belonging to infected 
flocks 
6.06% 6.99% 6.31% 
Non vaccinated 
animals belonging to 
infected flocks 
52.52% 46.04% 51.12% 
Mortality rate    
Infected flocks 12.77% 12.43% 12.68% 
Vaccinated animals 
belonging to infected 
flocks  
4.65% 6.41% 5.12% 
Non vaccinated 
animals belonging to 
infected flocks 
40.22% 39.11% 39.98% 
Source: National Food Directorate (Direction générale de l’Alimentation: 
DGAL) 
Comparison with the other 
Mediterranean islands 
The situation in Corsica is best compared to that of 
the other islands in the western Mediterranean where 
BT outbreaks due to BTV-2 were recorded, namely: 
Sardinia, Sicily and the Balearic islands (Fig. 5). The 
presence of C. imicola was confirmed in all of these 
islands except Ibiza (5). After one annual vaccination 
campaign from October 2000 to spring 2001, no 
clinical cases of BT were recorded in the Balearic 
islands (1). Only two annual vaccinations of sheep 
were necessary to obtain the same results in Corsica. 
In Sardinia, the vaccination coverage was between 
94.58-99.97% and in Sicily between 22.93-93.90% in 
2002 (2). In Sicily and Sardinia, clinical cases of BT 
were still recorded during 2002-2003 despite annual 
vaccination (10 and 53 outbreaks compared to 
6 090 and 6 in 2001-2002, respectively) using the 
same attenuated vaccine against BTV-2. Three 
important factors may explain this contrast: First, the 
sheep population is much greater on Sardinia and 
Sicily than on the other islands (Table V). It is also 
possible that an ‘island effect’ played a role in the 
extinction of BTV infection in the Balearic islands as 
the susceptible population may not have been 
sufficient to maintain the infection; similar findings 
have been observed with other contagious diseases 
like measles (3). Second, the geographic position of 
the different islands has to be taken into account. 
The Balearic islands are located 200 km from 
continental Spain but 350 km from Sardinia, whereas 
Corsica and Sardinia are separated by only 12 km, 
and Sicily and continental Italy are almost connected. 
It is then probable that only the Balearic islands can 
be considered an independent entity from an 
epidemiological perspective. The close interaction 
between Sicily and continental Italy is illustrated by 
the presence of the same serotypes of BTV in Sicily 
and Calabria (BTV serotypes 2 and 9). Third, 
vaccination in the Balearic islands was implemented 
very rapidly whereas it took three months in France. 
 
Figure 5 
Bluetongue in the larger islands of the Mediterranean, 
September 2003 
It is very important to evaluate the level of 
vaccination coverage that should be attained to 
eradicate disease, specifically the herd immunity 
threshold (HIT). An empirical evaluation gives 80% 
(Charles Nicolle’s law) but it has been shown that 
HIT calculation should be based on the evaluation 
  Clinical cases Circulation of BTV  
  serotypes 
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of the strength of spread of the disease measured by 
the basic reproduction ratio R0. Basically, if R0<1, 
the disease cannot persist in a population. Let R0 be 
the reproduction ratio in a population; to decrease 
R0 to a value below 1, a simple calculation indicates 
that the proportion of vaccinated animals should be 
more than 1-1/R0. In vector-borne diseases, several 
factors attributable to the vector will change the 
Table V 
Bluetongue in the larger islands of the Mediterranean 
BT clinical cases 
Island Area (km²) Sheep Goats Cattle First Last 
Sardinia 24 090 3 283 000 283 000 230 000 18 August2000 Ongoing 
Sicily 25 700 1 032 000 197 000 465 000 10 October 2000 Ongoing 
Corsica 8 682 137 000 24 800 55 860 18 September 2000 08 November 2001 
Ibiza 572    No outbreak  
Majorca 3 639 334 775 19 228 46 934   
Minorca 702   9 September 2000 27 November 2000 
 
approach (biting rate, trophic preferences, survival 
rate, incubation period and vectorial competency). 
Consequently, even with high vaccination coverage, 
it is still possible that the virus will persist in small 
areas or in reservoir animals. There is then a risk of 
re-emergence when coverage declines. For instance, 
the very high coverage in Sardinia in 2002 (from 
95% to 99%) did not prevent all outbreaks. 
Conclusion 
The experience in the Balearic islands, Corsica, Sicily 
and Sardinia showed that attenuated vaccine can 
safely be used to reduce the direct costs of BTV 
infection, i.e. morbidity and mortality in sheep. Even 
when side effects were reported by farmers, 
investigations did not confirm them. In September 
2003, the question for the French authorities was 
whether to stop vaccination after two years without 
any outbreaks of BT. However, this question has 
been negated by the occurrence of new outbreaks of 
BT due to serotype 4 in Sardinia. On 25 August 
2003, outbreaks were reported in Sardinia and 
serotype 4 was confirmed on 15 September 2003. It 
was then decided to vaccinate animals in Corsica 
against serotypes 2 and 4. In this case, the 
vaccination strategy was to prevent the establishment 
of the new serotype in Corsica. This experience 
illustrates the need for regional collaboration to 
define optimal vaccination strategies. The 
importance of information about circulating 
serotypes has also to be stressed. For this purpose, it 
is proposed that a Mediterranean information 
network be established for BT and other emerging 
diseases. 
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